During the past decade, Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" #1 sponsor was "Actelion" with 6 trials, followed by "Celgene" with 3 trials sponsored, "GlaxoSmithKline" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Merz Pharmaceuticals GmbH" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" are "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Hypertension, Pulmonary" (2 trials), "Multiple Sclerosis" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Subjective Tinnitus" (2 trials). Many other conditions were trialed in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" are "Drug" (22 trials), "Biological" (3 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Interferon beta-1a" (2 trials), "Macitentan" (2 trials), "Neramexane mesylate" (2 trials) and "Ozanimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ" are 23 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Wojewodzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego SPZOZ has several departments that took part in Clinical trials: "Oddzial Urazowo-Ortopedyczny Wojewodzki Szpital Specjalistyczny" - 2 trials